Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 5
2007 3
2008 4
2009 2
2010 1
2011 4
2012 11
2013 5
2014 1
2015 5
2016 1
2017 5
2018 5
2019 3
2020 5
2021 1
2022 1
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.
Sanchez MB, Vasconcelos Cordoba B, Pavlovsky C, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, García de Labanca A, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Levy EM, Bianchini M. Sanchez MB, et al. Among authors: mordoh j. Front Immunol. 2023 Sep 25;14:1241600. doi: 10.3389/fimmu.2023.1241600. eCollection 2023. Front Immunol. 2023. PMID: 37818372 Free PMC article. Clinical Trial.
HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI, Aris M, Panouillot M, Porto M, Dieu-Nosjean MC, Teillaud JL, Barrio MM, Mordoh J. Bravo AI, et al. Among authors: mordoh j. Front Immunol. 2023 Aug 25;14:1231734. doi: 10.3389/fimmu.2023.1231734. eCollection 2023. Front Immunol. 2023. PMID: 37691949 Free PMC article.
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study.
Villoldo GM, Pombo MT, Aris M, Chemi J, Mandó P, Nagaraju S, Camean J, Burioni A, Egea D, Amat M, Mellado JL, Mordoh J, Villaronga A, Barrio MM. Villoldo GM, et al. Among authors: mordoh j. Oncol Res. 2023 Apr 10;31(2):207-220. doi: 10.32604/or.2023.028163. eCollection 2023. Oncol Res. 2023. PMID: 37304240 Free PMC article.
Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.
Pavlovsky C, Vasconcelos Cordoba B, Sanchez MB, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, de Labanca AG, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Cueto G, Miranda S, Levy EM, Bianchini M. Pavlovsky C, et al. Among authors: mordoh j. J Hematol Oncol. 2023 Apr 29;16(1):43. doi: 10.1186/s13045-023-01440-6. J Hematol Oncol. 2023. PMID: 37120577 Free PMC article.
Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.
Bordignon MB, Pesce Viglietti AI, Juliá EP, Sanchez MB, Rölle A, Mandó P, Sabatini L, Ostinelli A, Rizzo MM, Barrio MM, Mordoh J, Fainboim L, Levy EM. Bordignon MB, et al. Among authors: mordoh j. Cancer Immunol Immunother. 2023 Aug;72(8):2687-2700. doi: 10.1007/s00262-023-03448-w. Epub 2023 Apr 21. Cancer Immunol Immunother. 2023. PMID: 37081323 Free PMC article.
An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.
Mordoh A, Aris M, Carri I, Bravo AI, Podaza E, Pardo JCT, Cueto GR, Barrio MM, Mordoh J. Mordoh A, et al. Among authors: mordoh j. Front Immunol. 2022 Apr 1;13:842555. doi: 10.3389/fimmu.2022.842555. eCollection 2022. Front Immunol. 2022. PMID: 35432383 Free PMC article. Clinical Trial.
miRNome profiling of LSC-enriched CD34+CD38-CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.
Ruiz MS, Sánchez MB, Bonecker S, Furtado C, Koile D, Yankilevich P, Cranco S, Custidiano MDR, Freitas J, Moiraghi B, Pérez MA, Pavlovsky C, Varela AI, Ventriglia V, Sánchez Ávalos JC, Larripa I, Zalcberg I, Mordoh J, Valent P, Bianchini M. Ruiz MS, et al. Among authors: mordoh j. Front Pharmacol. 2021 Jan 11;11:612573. doi: 10.3389/fphar.2020.612573. eCollection 2020. Front Pharmacol. 2021. PMID: 33569005 Free PMC article.
Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF.
Podaza E, Carri I, Aris M, von Euw E, Bravo AI, Blanco P, Ortiz Wilczyñski JM, Koile D, Yankilevich P, Nielsen M, Mordoh J, Barrio MM. Podaza E, et al. Among authors: mordoh j. Front Immunol. 2020 Jun 5;11:1147. doi: 10.3389/fimmu.2020.01147. eCollection 2020. Front Immunol. 2020. PMID: 32582212 Free PMC article. Clinical Trial.
67 results